Literature DB >> 17692569

Dendritic cell-endothelial cell cross-talk in angiogenesis.

Silvano Sozzani1, Marco Rusnati, Elena Riboldi, Stefania Mitola, Marco Presta.   

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells that have a pivotal role in the onset and regulation of adaptive immune responses. DCs have the ability to regulate inflammation through their capacity to release cytokines and chemokines and kill pathogens, which they share with other phagocytes. Recent observations have shown that different DC subsets produce and release various pro- and anti-angiogenic mediators depending on their activation status and cytokine milieu. In particular, alternatively activated DCs exert a potent pro-angiogenic activity that is mediated by the prototypic angiogenic growth factor vascular endothelial growth factor-A (VEGF-A). In turn, pro- and anti-angiogenic mediators can affect the biology of DCs, modulating their differentiation and maturation. Finally, DCs can trans-differentiate into endothelial-like cells, possibly contributing to vasculogenesis in the adult. Thus, DCs might exert an important impact on the neovascularization process in different physiopathological conditions.

Entities:  

Mesh:

Year:  2007        PMID: 17692569     DOI: 10.1016/j.it.2007.07.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  44 in total

1.  The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes.

Authors:  Francesca Bellora; Roberta Castriconi; Alessandra Dondero; Giorgio Reggiardo; Lorenzo Moretta; Alberto Mantovani; Alessandro Moretta; Cristina Bottino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

Review 2.  Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis.

Authors:  Katharina Schmidt-Bleek; Brian J Kwee; David J Mooney; Georg N Duda
Journal:  Tissue Eng Part B Rev       Date:  2015-04-01       Impact factor: 6.389

Review 3.  Manipulating the intersection of angiogenesis and inflammation.

Authors:  Brian J Kwee; David J Mooney
Journal:  Ann Biomed Eng       Date:  2014-10-15       Impact factor: 3.934

4.  The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Authors:  Leslee Sprague; Maria Muccioli; Michelle Pate; Evan Meles; John McGinty; Harika Nandigam; Amritha K Venkatesh; Ming-Yu Gu; Kristen Mansfield; Andrew Rutowski; Omowaleola Omosebi; Maria C Courreges; Fabian Benencia
Journal:  BMC Immunol       Date:  2011-06-06       Impact factor: 3.615

5.  Role of dendritic cells in cardiovascular diseases.

Authors:  Yi Zhang; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-11-26

Review 6.  Chemokines in health and disease.

Authors:  Dayanidhi Raman; Tammy Sobolik-Delmaire; Ann Richmond
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

Review 7.  Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors.

Authors:  Sara Mariucci; Bianca Rovati; Mariangela Manzoni; Matteo Giovanni Della Porta; Giuditta Comolli; Sara Delfanti; Marco Danova
Journal:  Clin Exp Med       Date:  2010-12-16       Impact factor: 3.984

Review 8.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

Review 9.  The VEGF pathway in cancer and disease: responses, resistance, and the path forward.

Authors:  Mark W Kieran; Raghu Kalluri; Yoon-Jae Cho
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

10.  Microglia and microglia-like cell differentiated from DC inhibit CD4 T cell proliferation.

Authors:  Bo Bai; Wengang Song; Yewei Ji; Xi Liu; Lei Tian; Chao Wang; Dongwei Chen; Xiaoning Zhang; Minghui Zhang
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.